Personalized Decision Making in Early Stage Breast Cancer: Applying Clinical Prediction Models for Anthracycline Cardiotoxicity and Breast Cancer Mortality Demonstrates Substantial Heterogeneity of Benefit-Harm Trade-off-Reference-Cited by-同舟云学术

Personalized Decision Making in Early Stage Breast Cancer: Applying Clinical Prediction Models for Anthracycline Cardiotoxicity and Breast Cancer Mortality Demonstrates Substantial Heterogeneity of Benefit-Harm Trade-off

Published:2019-08 Issue:4 Volume:19 Page:259-267.e1
ISSN:1526-8209
Container-title:Clinical Breast Cancer
language:en
Short-container-title:Clinical Breast Cancer

Author:

Upshaw Jenica N.^ORCID,Ruthazer Robin,Miller Kathy D.,Parsons Susan K.,Erban John K.^ORCID,O’Neill Anne M.,Demissei Biniyam,Sledge George^ORCID,Wagner Lynne,Ky Bonnie,Kent David M.

Funder

National Cancer Institute

Patient-Centered Outcomes Research Institute

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference28 articles.

1. Cancer statistics, 2017;Siegel;CA Cancer J Clin,2017

2. Cardiovascular disease mortality among breast cancer survivors;Bradshaw;Epidemiology,2016

3. Overall survival and cause-specific mortality of patients with stage T1a,bN0M0 breast carcinoma;Hanrahan;J Clin Oncol,2007

4. Shared risk factors for cardiovascular disease and cancer: implications for preventive health and clinical care in oncology patients;Johnson;Can J Cardiol,2016

5. Congestive heart failure in older women treated with adjuvant anthracycline chemotherapy for breast cancer;Pinder;J Clin Oncol,2007

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Health Literacy, Individual and Community Engagement, and Cardiovascular Risks and Disparities;JACC: CardioOncology;2024-06

2. Prediction of heart failure and all-cause mortality using cardiac ultrasomics in patients with breast cancer;The International Journal of Cardiovascular Imaging;2024-04-16

3. Advances in the care of breast cancer survivors;BMJ;2023-09-18

4. Risk Stratification for Cardiotoxicity in Breast Cancer Patients: Predicting Early Decline of LVEF After Treatment^*;2023 45th Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC);2023-07-24

5. Risk prediction models for antineoplastic-associated cardiotoxicity in treatment of breast cancer: A systematic review;American Journal of Health-System Pharmacy;2023-07-18